Day: March 5, 2025

Achieved record gross bookings of $65.8 million and revenue of $59.7 million in full-year 2024 Signed 46 new customers in 2024 and expanded relationship with existing customers across key markets including power, automotive, memory, foundry, and display Expanded Product Portfolio with the Acquisition of Cadence’s Process Proximity Compensation Product Line SANTA CLARA, Calif., March 05, 2025 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and automation, today announced its fourth quarter and full year 2024 results. “We are proud to close out the year with strong momentum and growing customer traction, including 46 new customer wins in 2024 and multiple...

Second Quarter HighlightsRevenue grows 23% year-over-year to $647.9 million Calculated billings grows 18% year-over-year to $742.7 million Deferred revenue grows 25% year-over-year to $1,878.5 million GAAP net loss of $7.7 million compared to GAAP net loss of $28.5 million on a year-over-year basis Non-GAAP net income of $127.1 million compared to non-GAAP net income of $99.4 million on a year-over-year basisSAN JOSE, Calif., March 05, 2025 (GLOBE NEWSWIRE) — Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today announced financial results for its second quarter of fiscal year 2025, ended January 31, 2025. “Growing adoption of Zero Trust and AI is driving strong demand for our platform, resulting in yet another strong quarter that exceeded our guidance on both top and bottom line. We are leading the industry towards...

Strong Power Product Sales for Data Centers Positive Free Cash Flow Transformation Journey Well Underway Guidance Reaffirmed for Fiscal 2026CHICAGO, March 05, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, today announced financial results for the third quarter of fiscal 2025 ended February 1, 2025. Fiscal Third Quarter 2025 ResultsNet sales were $239.9 million Electric and hybrid vehicle applications were 24% of net sales Pre-tax loss was $8.2 million; adjusted pre-tax loss was $7.3 million Tax expense of $6.2 million mainly due to a $6.5 million valuation allowance for U.S. deferred tax assets Net loss was $14.4 million, or $0.41 per diluted share Adjusted net loss was $7.2 million,...

MENLO PARK, Calif., March 05, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the fourth quarter and full year ended December 31, 2024 and initiated financial guidance for full year 2025. Recent Financial HighlightsGenerated fourth quarter 2024 total revenue of $19.1 million, an increase of 2% compared to the same period in the prior year, and full year 2024 total revenue of $79.9 million, a decrease of 1% compared to full year 2023. Achieved total gross margin of 87% of revenue in the fourth quarter of 2024 compared to 85% of revenue in the same period in the prior year, and...

JACKSONVILLE, Fla., March 05, 2025 (GLOBE NEWSWIRE) — FRP Holdings, Inc. (NASDAQ-FRPH)  FRP Holdings is a real estate asset developer and manager across three differing asset classes including Multifamily, Industrial and Commercial, and Mining and Royalty Lands. Net Income Results – Net income for the fourth quarter of 2024 was $1,679,000 or $.09 per share versus $2,880,000 or $.15 per share in the fourth quarter of 2023. Net income for 2024 was $6,385,000 or $.34 per share versus $5,302,000 or $.28 per share in 2023. Executive Summary and Analysis – In the fourth quarter, the Company saw a 21% improvement in pro rata NOI compared to the same period last year, and for the year ended December 31, 2024 saw a 26% increase in pro rata NOI ($38.1 million vs $30.2 million) compared to 2023. This is consistent with the almost 30%...

HOUSTON, March 05, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today its operating and financial results for the fourth quarter and full-year 2024, year-end 2024 proved reserves, Juniper Capital (“Juniper”) acquisition update and full-year 2025 standalone guidance for the Company. Key Highlights2025 strategic initiatives include:Completing the previously announced transformational combination with certain Juniper portfolio companies which own substantial oil-weighted producing assets and significant leasehold interests in the DJ and Powder River Basins (the “Transaction”) and integrating such assets into our operations Continuing the Beta development program with six completions planned for 2025 including the C-48 and the A-45 which were deferred from the 2024...

FY 2024 Revenue up 40% to $223.8 Million MIAMI, March 05, 2025 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the “Company” or “GlobalX”), the Nation’s fastest growing charter airline, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2024. Except as otherwise disclosed, all figures for the three- and twelve-month period are presented in United States dollars and prepared in accordance with U.S. GAAP. Financial and Operational Summary  Q4 2024 Q4 2023 % ChangeRevenue: $59.9M $53.9M 11%Net Income (Loss): $(0.6)M $(2.6)M N/AAdjusted Net Income (Loss) 1: $1.2M $(1.8)M N/AEBITDAR1: $19.3M $11.4M 69%EBITDA1: $5.1M $(0.4)M N/ANet Aircraft Available: 15.6 11.5 36%Total Block Hours, including...

Appointed Ajay Amlani as the new Chief Executive Officer. BURLINGTON, Mass., March 05, 2025 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data science and machine learning to tackle everyday business and identity challenges through biometrics, today reported financial results for the fourth quarter and fiscal year ended December 31, 2024. Full Year 2024 Financial OverviewTotal revenue decreased 5% to $17.4 million from $18.2 million in 2023. Recurring revenue increased 9% to $12.0 million, compared to $11.0 million in 2023. Net loss improved 39% to $4.4 million, compared to $7.3 million in 2023. 2023 was negatively impacted by the $2.7 million write-off related to March 2022 investment in Omlis Limited. Adjusted EBITDA loss improved 15% to $3.9 million compared to $4.6 million in...

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe SLE Completed Type D Meeting with FDA to Enable FT819 Off-the-Shelf CAR T-cell Dose Expansion in Additional B Cell-mediated Autoimmune Diseases First FT819 Off-the-Shelf CAR T-cell Patient Treated without Conditioning Chemotherapy as Add-on to Maintenance Therapy in SLE $307 Million in Cash, Cash Equivalents and Investments with Projected Operating Runway through YE26 SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today reported business highlights and financial results for the...